Show simple item record

dc.contributor.authorBeg, Sabina
dc.contributor.authorFateen, Waleed
dc.contributor.authorSami, Sarmed S.
dc.contributor.authorRagunath, Krish
dc.date.accessioned2023-11-01T15:59:14Z
dc.date.available2023-11-01T15:59:14Z
dc.identifier.citationDesai, M., Srinivasan, S., Sundaram, S., Dasari, C., Andraws, N., Mathur, S., Higbee, A., Miller, J., Beg, S., Fateen, W., Sami, S.S., Repici, A., Ragunath, K. and Sharma, P. (2022) 'Narrow-band imaging for the diagnosis of nonerosive reflux disease: An international, multicenter, randomized controlled trial', Gastrointestinal Endoscopy, 96(3), pp. 457-466.e3. doi: 10.1016/j.gie.2022.04.020 https://doi.org/10.1016/j.gie.2022.04.020.en_US
dc.identifier.issn1097-6779
dc.identifier.issn0016-5107
dc.identifier.urihttp://hdl.handle.net/20.500.12904/17762
dc.descriptionAvailable to view at the publisher's website here: https://doi.org/10.1016/j.gie.2022.04.020.en_US
dc.description.abstractBACKGROUND AND AIMS: We examined the accuracy of narrow-band imaging (NBI) findings in nonerosive reflux disease (NERD) patients compared with control subjects and the impact of proton pump inhibitor (PPI) therapy on these mucosal changes in a multicenter, double-blind, randomized controlled trial. METHODS: NERD patients (typical symptoms using a validated GERD questionnaire, absence of erosive esophagitis, and abnormal 48-hour pH study) and control subjects underwent high-definition white-light endoscopy followed by NBI and biopsy sampling of the distal esophagus. Then, NERD patients were randomized to esomeprazole 40 mg/day or placebo for 8 weeks, followed by repeat endoscopy. The presence of distal esophageal mucosal changes on NBI were recorded at baseline and after treatment: intrapapillary capillary loops (IPCLs; number, dilation, and tortuosity), microerosions, increased vascularity, columnar islands, and ridge/villous pattern (RVP) above the squamocolumnar junction. RESULTS: Of 122 screened, 21 NERD and 21 control subjects were identified (mean age, 49.5 +/- 14.6 years; 62% men; and 85% white). The combination of IPCL tortuosity, RVP, and microerosions (62% vs 19%, P Copyright © 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
dc.description.urihttps://doi.org/10.1016/j.gie.2022.04.020en_US
dc.language.isoenen_US
dc.subjectGastro-oesophageal refluxen_US
dc.subjectNarrow band imagingen_US
dc.subjectControlled trialen_US
dc.titleNarrow-band imaging for the diagnosis of nonerosive reflux disease: An international, multicenter, randomized controlled trialen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2022
html.description.abstractBACKGROUND AND AIMS: We examined the accuracy of narrow-band imaging (NBI) findings in nonerosive reflux disease (NERD) patients compared with control subjects and the impact of proton pump inhibitor (PPI) therapy on these mucosal changes in a multicenter, double-blind, randomized controlled trial. METHODS: NERD patients (typical symptoms using a validated GERD questionnaire, absence of erosive esophagitis, and abnormal 48-hour pH study) and control subjects underwent high-definition white-light endoscopy followed by NBI and biopsy sampling of the distal esophagus. Then, NERD patients were randomized to esomeprazole 40 mg/day or placebo for 8 weeks, followed by repeat endoscopy. The presence of distal esophageal mucosal changes on NBI were recorded at baseline and after treatment: intrapapillary capillary loops (IPCLs; number, dilation, and tortuosity), microerosions, increased vascularity, columnar islands, and ridge/villous pattern (RVP) above the squamocolumnar junction. RESULTS: Of 122 screened, 21 NERD and 21 control subjects were identified (mean age, 49.5 +/- 14.6 years; 62% men; and 85% white). The combination of IPCL tortuosity, RVP, and microerosions (62% vs 19%, P Copyright © 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record